title: Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency.
authors.forename: Raymond S M
authors.initials: RS
authors.lastname: Wong
authors.forename: Gregory
authors.initials: G
authors.lastname: Cheng
authors.forename: Natalie P H
authors.initials: NP
authors.lastname: Chan
authors.forename: Wai-Shan
authors.initials: WS
authors.lastname: Wong
authors.forename: Margaret H L
authors.initials: MH
authors.lastname: NG
mesh_terms: D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors / Q000032:analysis; D016913:Blood Component Transfusion; D002438:Cefoperazone / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006417:Hematuria / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000652:urine; D006801:Humans; D007262:Infusions, Intravenous; D010949:Plasma; D014812:Vitamin K / Q000008:administration & dosage; D014813:Vitamin K Deficiency / Q000097:blood / Q000209:etiology* / Q000628:therapy / Q000652:urine
chemical_list: D000900:Anti-Bacterial Agents; D001779:Blood Coagulation Factors; D014812:Vitamin K; D002438:Cefoperazone